1. Home
  2. HCM vs PRVA Comparison

HCM vs PRVA Comparison

Compare HCM & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • PRVA
  • Stock Information
  • Founded
  • HCM 2000
  • PRVA 2007
  • Country
  • HCM Hong Kong
  • PRVA United States
  • Employees
  • HCM N/A
  • PRVA 1140
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • PRVA Retail: Computer Software & Peripheral Equipment
  • Sector
  • HCM Health Care
  • PRVA Technology
  • Exchange
  • HCM Nasdaq
  • PRVA Nasdaq
  • Market Cap
  • HCM 2.5B
  • PRVA 2.8B
  • IPO Year
  • HCM N/A
  • PRVA 2021
  • Fundamental
  • Price
  • HCM $14.84
  • PRVA $21.85
  • Analyst Decision
  • HCM Hold
  • PRVA Strong Buy
  • Analyst Count
  • HCM 1
  • PRVA 14
  • Target Price
  • HCM $19.00
  • PRVA $27.93
  • AVG Volume (30 Days)
  • HCM 90.6K
  • PRVA 792.8K
  • Earning Date
  • HCM 07-30-2025
  • PRVA 08-07-2025
  • Dividend Yield
  • HCM N/A
  • PRVA N/A
  • EPS Growth
  • HCM N/A
  • PRVA N/A
  • EPS
  • HCM 0.04
  • PRVA 0.12
  • Revenue
  • HCM $630,201,000.00
  • PRVA $1,801,244,000.00
  • Revenue This Year
  • HCM $14.86
  • PRVA $90.63
  • Revenue Next Year
  • HCM $19.54
  • PRVA $10.51
  • P/E Ratio
  • HCM $66.84
  • PRVA $182.49
  • Revenue Growth
  • HCM N/A
  • PRVA 6.79
  • 52 Week Low
  • HCM $11.51
  • PRVA $16.37
  • 52 Week High
  • HCM $21.50
  • PRVA $26.09
  • Technical
  • Relative Strength Index (RSI)
  • HCM 46.89
  • PRVA 34.75
  • Support Level
  • HCM $15.02
  • PRVA $22.01
  • Resistance Level
  • HCM $18.00
  • PRVA $23.28
  • Average True Range (ATR)
  • HCM 0.42
  • PRVA 0.72
  • MACD
  • HCM -0.04
  • PRVA -0.11
  • Stochastic Oscillator
  • HCM 31.45
  • PRVA 11.46

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About PRVA Privia Health Group Inc.

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Share on Social Networks: